Podium to Practice: ESMO® 2026 – GI: AZUR-1

Studies / Trials Discussed

LBA87 – Clinical Complete Response With Dostarlimab Monotherapy in dMMR/MSI-H Locally Advanced Rectal Cancer (LARC): First Results From the Global Registrational AZUR-1 Trial

Explore more from your favourite experts – click their name to access their entire library of content.

Studies/trials discussed:

LBA87 – Clinical Complete Response With Dostarlimab Monotherapy in dMMR/MSI-H Locally Advanced Rectal Cancer (LARC): First Results From the Global Registrational AZUR-1 Trial